Stocksigma LogoStocksigma Logo

Alivus Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

■ Revenue: 6,820 (+16.0% YoY | +6.5% QoQ) ■ EBITDA: 2,652 (+48.0% YoY | +25.3% QoQ) ■ EBITDA Margin (%): 38.9 (+841 bps YoY | +583 bps QoQ) ■ PAT: 1,967

Alivus Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

Alivus Life Sciences Ltd · Financial Result · 30 Oct 2026, 12:51 am

Alivus Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 6,820 (+16.0% YoY | +6.5% QoQ) ■ EBITDA: 2,652 (+48.0% YoY | +25.3% QoQ) ■ EBITDA Margin (%): 38.9 (+841 bps YoY | +583 bps QoQ) ■ PAT: 1,967 (+51.3% YoY | +22.9% QoQ) ■ EPS (INR): 16.0 (+51.0% YoY | +22.8% QoQ)

Original exchange filing (PDF)

More announcements from Alivus Life Sciences Ltd

All Alivus Life Sciences Ltd announcements